Pure Global
NCT06409624

Association Between Biomarkers and eGFR Decline in Pulmonary Hypertension

Association Between Biomarkers and Decline in Estimated Glomerular Filtration Rate in Patients With Pulmonary Hypertension
University of Giessen·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
No intervention is planned as part of the study
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
University of Giessen
Location
Giessen, Germany
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Jul 01, 2026
Enrollment
200 participants
Primary outcome

Kidney function decline

Summary

The objective of this study is to examine the association between urinary and plasma
 biomarkers and the change of estimated glomerular filtration rate (eGFR) in patients with
 pulmonary hypertension (PH) as a tool to identify patients at high risk for short-term eGFR
 decline.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409624
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06409624 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Giessen and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.